Form D · Other Health Care
ProVerde Laboratories, Inc.
Milford, MA · CIK 0001638048
Offering snapshot reported Jul 23, 2018 · SEC filing
- Reported sold
- $2.12M Offering amount: $4M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 29, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 23, 2018 | Initial | $2,120,000 | No comparison | 13 | SEC filing |
| Mar 30, 2015 | Initial | $640,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-317509
Source: Form D, filed Jul 23, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dorian Des Lauriers | Director, Executive |
| Christopher Hudella | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
420 Fortune Blvd
Milford, MA, 01757
Milford, MA, 01757